Gary P. Naegel

1.1k total citations
19 papers, 887 citations indexed

About

Gary P. Naegel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Gary P. Naegel has authored 19 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Gary P. Naegel's work include Inhalation and Respiratory Drug Delivery (10 papers), Cystic Fibrosis Research Advances (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Gary P. Naegel is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Cystic Fibrosis Research Advances (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Gary P. Naegel collaborates with scholars based in United States. Gary P. Naegel's co-authors include Herbert Y. Reynolds, Richard A. Matthay, William W. Merrill, Robert B. Fick, Susan U. Squier, J. Bernard L. Gee, Robert E. Wood, John A. Rankin, J. C. Rankin and William Merrill and has published in prestigious journals such as Journal of Clinical Investigation, Annals of the New York Academy of Sciences and CHEST Journal.

In The Last Decade

Gary P. Naegel

17 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary P. Naegel United States 13 552 193 174 162 127 19 887
John A. Kazmierowski United States 13 585 1.1× 189 1.0× 276 1.6× 155 1.0× 95 0.7× 19 1.2k
Alison H. Rose Australia 15 309 0.6× 298 1.5× 261 1.5× 95 0.6× 45 0.4× 24 778
Paul Borron United States 9 594 1.1× 119 0.6× 336 1.9× 99 0.6× 89 0.7× 12 803
S. Suter Switzerland 14 413 0.7× 57 0.3× 113 0.6× 200 1.2× 158 1.2× 27 805
S. L. Hill United Kingdom 14 386 0.7× 141 0.7× 97 0.6× 134 0.8× 126 1.0× 22 688
Hans‐Peter Hauber Germany 15 333 0.6× 256 1.3× 163 0.9× 80 0.5× 154 1.2× 34 748
Jp. Vaerman Belgium 12 138 0.3× 97 0.5× 297 1.7× 100 0.6× 136 1.1× 22 728
N. Bilyk Australia 9 165 0.3× 292 1.5× 608 3.5× 125 0.8× 73 0.6× 12 878
Y.‐K. Kim South Korea 17 152 0.3× 298 1.5× 160 0.9× 73 0.5× 237 1.9× 26 764
Chad W. Dunaway United States 16 173 0.3× 198 1.0× 318 1.8× 198 1.2× 134 1.1× 18 794

Countries citing papers authored by Gary P. Naegel

Since Specialization
Citations

This map shows the geographic impact of Gary P. Naegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary P. Naegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary P. Naegel more than expected).

Fields of papers citing papers by Gary P. Naegel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary P. Naegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary P. Naegel. The network helps show where Gary P. Naegel may publish in the future.

Co-authorship network of co-authors of Gary P. Naegel

This figure shows the co-authorship network connecting the top 25 collaborators of Gary P. Naegel. A scholar is included among the top collaborators of Gary P. Naegel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary P. Naegel. Gary P. Naegel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cullen, Mark R., Milton D. Rossman, Martin G. Cherniack, et al.. (2015). Chronic Beryllium Disease in a Precious Metal Refinery. American Review of Respiratory Disease.
2.
Sibille, Yves, et al.. (1989). Human Alveolar Macrophages Release a Factor That Inhibits Phagocyte Function. American Journal of Respiratory Cell and Molecular Biology. 1(5). 407–416. 12 indexed citations
3.
Sibille, Yves, et al.. (1987). Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.. PubMed. 110(5). 624–33. 19 indexed citations
4.
Cullen, Mark R., Milton D. Rossman, Martin G. Cherniack, et al.. (1987). Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.. PubMed. 135(1). 201–8. 37 indexed citations
5.
Rankin, John A., Gary P. Naegel, & Herbert Y. Reynolds. (1986). Use of a central laboratory for analysis of bronchoalveolar lavage fluid.. PubMed. 133(2). 186–90. 23 indexed citations
6.
Rankin, John A., et al.. (1986). Immunoglobulin G Subclasses in Sarcoidosis. Annals of the New York Academy of Sciences. 465(1). 122–129. 2 indexed citations
7.
Merrill, William W., et al.. (1985). Immunoglobulin G Subclass Proteins in Serum and Lavage Fluid of Normal Subjects. American Review of Respiratory Disease. 131(4). 584–587. 94 indexed citations
8.
Merrill, William W., Kenneth W. Barwick, Joseph A. Madri, et al.. (1984). Bronchial lavage proteins as correlates of histopathologic airway changes in healthy smokers and patients with pulmonary carcinoma.. PubMed. 130(5). 905–9. 7 indexed citations
9.
Fick, Robert B., Gary P. Naegel, Susan U. Squier, et al.. (1984). Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.. Journal of Clinical Investigation. 74(1). 236–248. 167 indexed citations
10.
Rankin, John A., Gary P. Naegel, Carol E. Schrader, Richard A. Matthay, & Herbert Y. Reynolds. (1983). Air-Space Immunoglobulin Production and Levels in Bronchoalveolar Lavage Fluid of Normal Subjects and Patients with Sarcoidosis 1– 4. American Review of Respiratory Disease. 127(4). 442–448. 60 indexed citations
11.
Merrill, William, et al.. (1982). Kinetic analysis of respiratory tract proteins recovered during a sequential lavage protocol.. PubMed. 126(4). 617–20. 77 indexed citations
12.
Merrill, William W., et al.. (1981). Quantitation of carcinoembryonic antigen in the lung lining fluid of normal smokers and nonsmokers.. PubMed. 123(1). 29–31. 28 indexed citations
13.
Fick, Robert B., Gary P. Naegel, Richard A. Matthay, & Herbert Y. Reynolds. (1981). Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.. Journal of Clinical Investigation. 68(4). 899–914. 66 indexed citations
14.
Merrill, William W., Daniel M. Goodenberger, Warren Strober, et al.. (1980). Free secretory component and other proteins in human lung lavage.. PubMed. 122(1). 156–61. 54 indexed citations
15.
Merrill, William W., Gary P. Naegel, Richard A. Matthay, & Herbert Y. Reynolds. (1980). Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.. Journal of Clinical Investigation. 65(2). 268–276. 204 indexed citations
16.
Fick, Robert B., Gary P. Naegel, & Herbert Y. Reynolds. (1980). Use of Pseudomonas Aeruginosa lipopolysaccharide immunoadsorbents to prepare high potency, mono-specific antibodies. Journal of Immunological Methods. 38(1-2). 103–116. 19 indexed citations
17.
Merrill, William W., Gary P. Naegel, Richard A. Matthay, & Herbert Y. Reynolds. (1979). Production of Chemotactic Factor(s) by in vivo Cultured Human Alveolar Macrophages. CHEST Journal. 75(2). 224–224.
18.
Merrill, William W., Gary P. Naegel, Richard A. Matthay, & Herbert Y. Reynolds. (1979). Production of Chemotactic Factor(s) by in vivo Cultured Human Alveolar Macrophages. CHEST Journal. 75(2). 224–224. 4 indexed citations
19.
Reynolds, Herbert Y., et al.. (1978). Immunoglobulin A in Secretions from the Lower Human Respiratory Tract. Advances in experimental medicine and biology. 107. 553–564. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Kazmierowski Breakdown of academic impact, for papers by Alison H. Rose Breakdown of academic impact, for papers by Paul Borron Breakdown of academic impact, for papers by S. Suter Breakdown of academic impact, for papers by S. L. Hill Breakdown of academic impact, for papers by Hans‐Peter Hauber Breakdown of academic impact, for papers by Jp. Vaerman Breakdown of academic impact, for papers by N. Bilyk Breakdown of academic impact, for papers by Y.‐K. Kim Breakdown of academic impact, for papers by Chad W. Dunaway
Rankless by CCL
2026